The Folio · November 2026Pan-India · more than 200 lawyersMumbai · New Delhi · Bengaluru
White & Brief — Advocates and Solicitors Contact →
White & Brief/Practices/Rights, technology & media
The Folio · Practice · Rights, technology & media

Patents — Pharma, Biotech & Chemicals

Life-sciences inventions protected from the first draft to the High Court: drafting and prosecution, oppositions, freedom to operate, and the licences that take research to market.

Led by Mr. Varunraj Limaye, with Mr. Rahul Dhote.

Advocate and patent agentProsecution to enforcementResearch institutions
Patents — Pharma, Biotech & Chemicals.
Patents — Pharma, Biotech & Chemicals.
DraftingProsecutionPre-grant oppositionsPost-grant oppositionsSection 3(d)Freedom to operateLandscapingTechnology transfer
PharmaceuticalsBiopharmaceuticalsChemicalsMedical devicesDiagnosticsNutraceuticalsUniversities
I · The Brief

What clients bring us.

In pharmaceuticals and chemistry, an Indian patent is won or lost on the drafting and on Section 3(d), and challenged by competitors through oppositions that run for years. Research institutions face a different problem: inventions that are never filed, or filed without a policy for who owns and licenses them.

Mr. Varunraj Limaye, an advocate and registered patent agent trained in science, leads the life-sciences patents desk. He has more than sixteen years across Indian and US patent law and led the Mumbai office of K&S Partners before joining the firm with Mr. Rahul Dhote's team.

II · The Remit

What we handle.

Before courts, tribunals, regulators and counterparties across India.

  • IPatent drafting and prosecution before the Indian Patent Office
  • IIPre-grant and post-grant oppositions
  • IIIFreedom-to-operate and validity opinions
  • IVPatent landscaping
  • VPatent enforcement before the High Courts
  • VIIP policy and technology licensing for research institutions
  • VIIMedical-device and diagnostics patents
  • VIIIFixed-fee patent packages
III · The Record

Types of work, without client names.

Described without client names, as the Bar Council of India rules require.

I

Pharmaceutical and chemical companies

Prosecution and opposition strategy for incremental innovations.

II

Research institutions and universities

IP policies, filings and licences that take research to industry.

IV · The Method

How we work.

The science is read before the law. Claims are drafted with the opposition in mind, because in India the opposition usually comes.

What to send us firstThe invention disclosure, any prior-art searches, the target markets, and the filing history if an application exists.
VI · The Pen

Forthcoming from the partners.

Mr. Varunraj Limaye

Section 3(d) and incremental innovation: where the line sits now

Mr. Varunraj Limaye

Pre-grant oppositions: timelines and strategy

Mr. Varunraj Limaye

University IP policies and spin-outs: getting the licence right

Under the rules of the Bar Council of India, White & Brief may not advertise or solicit work. By continuing you confirm that you are seeking information about the firm on your own initiative, and that nothing on this site is legal advice.